TCL Archive FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds December 26, 2003
TCL Archive NCI Considers ‘Decentralization’ Of Group C To Provide Wider Access, Local Flexibility September 7, 1990
TCL Archive Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer June 5, 2009
TCL Archive New Group Review First NTP Reports, Gets Job On Permanent Basis, Wrangles Over Extrapolation July 11, 1980